This inventor holds 3 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 4 EPO patents. Top assignees: Cj Cheiljedang Corporation, Cj Healthcare Corporation, Hk Inno.n Corporation. Active years: 2017-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 977 
1 out of 14 
1 out of 15 Years Active: 2017-2021
Title: Geun Seog Song: Innovator in Gastric Acid Treatment
Introduction
Geun Seog Song is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of medicine, particularly in the treatment of gastric acid-related diseases. With a total of 3 patents, his work focuses on innovative solutions for improving patient outcomes.
Latest Patents
One of his latest patents is titled "Uses of benzimidazole derivative for nocturnal acid breakthrough." This invention relates to the use of benzimidazole derivative compounds aimed at improving and treating nocturnal acid breakthrough (NAB). The compounds developed by Song can effectively prevent and treat symptoms associated with gastric acid-related diseases, offering a promising avenue for patients suffering from these conditions.
Career Highlights
Throughout his career, Geun Seog Song has worked with prominent companies in the healthcare sector, including Hk Inno.n Corporation and CJ Healthcare Corporation. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical treatments.
Collaborations
Some of his notable coworkers include Ha Jin Lee and Bong Tae Kim. Their collaborative efforts have likely played a role in the development of his patented inventions.
Conclusion
Geun Seog Song's contributions to the field of medicine through his patents demonstrate his commitment to improving healthcare solutions. His innovative work in treating gastric acid-related diseases highlights the importance of ongoing research and development in this area.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile